KMT2A and acute lymphoblastic leukemia: With a literature-similar profile [12], 22.2% of young ALL patients had BCR::ABL1, SET::NUP214, STIL::TAL1, MLL::AFF1, and MLL::MLLT10 fusions, and 11.1% had MLL::ELL fusion.